Richard Aguilar - Mar 31, 2023 Form 4 Insider Report for Cano Health, Inc. (CANO)

Role: Chief Clinical Officer
Signature: /s/ David J. Armstrong, Attorney-in-Fact
Stock symbol: CANO
Transactions as of: Mar 31, 2023
Transactions value $: $0
Form type: 4
Date filed: 4/4/2023, 08:40 PM
Previous filing: Jan 9, 2023
Next filing: Apr 6, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CANO	Class A Common Stock	Award		+120K	+13.92%		983K	Mar 31, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CANO	Stock Option (Right to Buy)	Award	$0	+196K		$0.00	196K	Mar 31, 2023	Class A Common Stock	196K	$0.91	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units ("RSUs") granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan. Each unit represents a right to receive one share of the Issuer's Class A Common Stock. The RSUs vest as to 50% of the RSUs on December 31st, 2023 and the remaining 50% of the RSUs vest on December 31st, 2024. The RSUs were granted on March 31, 2023.
F2	The stock option is granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan and is scheduled to vest over four years, with 25% of the shares underlying the award vesting on March 31, 2024, and 25% of the shares underlying the award vesting at the end of each successive one-year period thereafter. The stock option was granted on March 31, 2023.